Loading
Latest filing published 02 Oct 2023 for Design Therapeutics, Inc., €47k. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Rodney W. Lappe in Design Therapeutics, Inc. Between 9 December 2022 and 29 September 2023, the trades on record add up to 2 filings.
On the market, this insider has only ever bought: 2 purchases, €160k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2023: 1 purchase and no sales on the market.
On 2 October 2023 came the latest disclosure, an open-market purchase for €47k in Design Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations